Anti-CUX2 monoclonal antibody

Pre-made anti-CUX2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CUX2/CUX2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0630-Ab-1/ GM-Tg-hg-IP0630-Ab-2Anti-Human CUX2 monoclonal antibodyHuman
GM-Tg-rg-IP0630-Ab-1/ GM-Tg-rg-IP0630-Ab-2Anti-Rat CUX2 monoclonal antibodyRat
GM-Tg-mg-IP0630-Ab-1/ GM-Tg-mg-IP0630-Ab-2Anti-Mouse CUX2 monoclonal antibodyMouse
GM-Tg-cynog-IP0630-Ab-1/ GM-Tg-cynog-IP0630-Ab-2Anti-Cynomolgus/ Rhesus macaque CUX2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0630-Ab-1/ GM-Tg-felg-IP0630-Ab-2Anti-Feline CUX2 monoclonal antibodyFeline
GM-Tg-cang-IP0630-Ab-1/ GM-Tg-cang-IP0630-Ab-2Anti-Canine CUX2 monoclonal antibodyCanine
GM-Tg-bovg-IP0630-Ab-1/ GM-Tg-bovg-IP0630-Ab-2Anti-Bovine CUX2 monoclonal antibodyBovine
GM-Tg-equg-IP0630-Ab-1/ GM-Tg-equg-IP0630-Ab-2Anti-Equine CUX2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0630-Ab-1/ GM-Tg-hg-IP0630-Ab-2; GM-Tg-rg-IP0630-Ab-1/ GM-Tg-rg-IP0630-Ab-2;
GM-Tg-mg-IP0630-Ab-1/ GM-Tg-mg-IP0630-Ab-2; GM-Tg-cynog-IP0630-Ab-1/ GM-Tg-cynog-IP0630-Ab-2;
GM-Tg-felg-IP0630-Ab-1/ GM-Tg-felg-IP0630-Ab-2; GM-Tg-cang-IP0630-Ab-1/ GM-Tg-cang-IP0630-Ab-2;
GM-Tg-bovg-IP0630-Ab-1/ GM-Tg-bovg-IP0630-Ab-2; GM-Tg-equg-IP0630-Ab-1/ GM-Tg-equg-IP0630-Ab-2
Products NameAnti-CUX2 monoclonal antibody
Formatmab
Target NameCUX2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CUX2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0630-Ag-1Recombinant multi-species CUX2/ CDP2/ CUTL2 protein


    Target information

    Target IDGM-IP0630
    Target NameCUX2
    Gene ID23316,13048,288665,712795,486267,101081500,524491,100630554
    Gene Symbol and Synonyms1700051K22Rik,CDP2,CUTL2,Cux-2,CUX2,DEE67,EIEE67
    Uniprot AccessionO14529
    Uniprot Entry NameCUX2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000111249
    Target ClassificationN/A

    The target: CUX2, gene name: CUX2, also named as CDP2, CUTL2, EIEE67. This gene encodes a protein which contains three CUT domains and a homeodomain; both domains are DNA-binding motifs. A similar gene, whose gene product possesses different DNA-binding activities, is located on chromosome on chromosome 7. Two pseudogenes of this gene have been identified on chromosomes 10 and 4. [provided by RefSeq, Jan 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.